
News|Articles|October 1, 2005
Pipeline Preview
Nelarabine (Arranon, GlaxoSmithKline) injection for the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in pediatric and adult patients whose disease has not responded to or has relapsed following treatment with at least 2 chemotherapy regimens.
Advertisement
Recommendations for accelerated approval
Recommendations for approval
Orphan drug designations
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Music and painting dual art therapy improves cognitive and social functions of hospitalized schizophrenia patients, study suggests
2
Biosimilars in 2025: A year of firsts
3
Looking ahead: What the MHE 2025 State of the Industry survey tells us about 2026
4
Japanese study finds vitiligo has a strong impact on daily life and mental health
5






















































